Search for: "MAJOR PHARMACEUTICALS"
Results 61 - 80
of 4,359
Sorted by Relevance
|
Sort by Date
13 Sep 2012, 9:59 pm
Par Pharmaceutical, Inc., thereby allowing Santarus to keep Par's generic version of Zegerid® off the market until the expiration of the Orange Book-listed patents. [read post]
4 May 2017, 1:00 am
The patentee’s major appeal grounds include that the structure of the claimed polymorph shall not be regarded similar to those in the prior art, and the crystalline structure per se is unobvious. [read post]
14 Jan 2021, 5:14 am
The new regulations primarily target pharmaceutical companies that are intending to sell and prescribe marijuana to patients. [read post]
28 Oct 2007, 2:34 am
The Pharmaceutical Encyclopedia shows that pharmacies in Australia are mostly franchises of retail brands offered by the three major pharmaceutical wholesalers in Australia â€â [read post]
1 Jun 2023, 2:23 pm
The Court revived qui tam whistleblower lawsuits against pharmaceutical companies who allegedly overbilled Medicare and Medicaid. [read post]
2 Nov 2012, 9:44 am
Pharmaceuticals, Luitpold Pharmaceuticals and Sandoz. [read post]
7 Aug 2012, 7:27 am
In Momenta Pharmaceuticals, Judge Moore (writing for the majority joined by Judge Dyk) ruled that this “safe harbor” could also apply to post-FDA approval activity, even if that activity was at least arguably commercial in nature. [read post]
11 Sep 2012, 5:30 am
In Momenta Pharmaceuticals, Judge Moore (writing for the majority joined by Judge Dyk) ruled that this “safe harbor” could also apply to post-FDA approval activity, even if that activity was at least arguably commercial in nature.... [read post]
12 May 2009, 3:43 pm
In 2007 Amylin Pharmaceuticals issued 3.00% convertible senior notes due 2014. [read post]
21 Jun 2007, 9:52 pm
Noonan -- Federal District Court Judge Patti Saris handed down her decision in a major class action suit against several pharmaceutical companies, and the pharmaceutical companies cannot be happy with the result. [read post]
25 Feb 2012, 10:04 am
One of the major problems in coverage in the new Manual is its inconsistent, sparse, and at points out-dated treatment of meta-analysis. [read post]
22 Jul 2008, 3:36 am
By Sherri Oslick -- In a transaction merging two major players in the generic pharmaceutical arena, Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced late last week that they have entered into an agreement by which Teva will acquire Barr for $7.46 billion plus the assumption of $1.5 billion in debt. [read post]
8 Feb 2007, 8:40 pm
Speakers include in-house counsel from major pharmaceutical companies as well as outside counsel who specialize in this area. [read post]
26 Feb 2020, 2:10 pm
The outline of Mallinckrodt Pharmaceutical’s chapter 11 proposal (no filing yet) puzzles me. [read post]
24 May 2012, 12:02 pm
The exempt status of pharmaceutical sales representatives is a hotly litigated issue because pharmaceutical sales representatives do not actually consummate sales. [read post]
13 Aug 2012, 9:41 pm
Noonan -- Judge Rader wrote a vigorous dissent to the panel majority's opinion in Momenta v. [read post]
10 Aug 2013, 4:04 pm
Olanzapine, a common anti-psychotic drug used to treat illnesses such as schizophrenia and bipolar disorder, has been recalled by its manufacturer in light of major defects in the drug’s packaging. [read post]
24 Jun 2020, 6:52 am
The Supreme Court allowed Kymab’s appeal by a majority of four to one, holding that the patents are invalid. [read post]
19 Jul 2012, 8:07 am
In light of news from Europe today, via the IPKat, it is becoming ever more clear that the law in Australia regarding the grant of extensions of term for pharmaceutical patents is flawed, and out-of-step with all of our major trading partners. [read post]
22 Sep 2017, 10:04 am
“By no one’s math is 50 percent a vast majority,” said Paul Levenson, Director of the SEC’s Boston Regional Office. [read post]
